Getting an Accurate Diagnosis

Because AA amyloidosis is caused by long-term inflammation, its symptoms often appear slowly and may be mistaken for the underlying disease itself. However, identifying these signs early is the first step toward the diagnostic process that ensures you receive the correct treatment ^[1].

Recognizing the Signs of AA Amyloidosis

In the majority of cases, AA amyloidosis first shows up in the kidneys ^[1][2]. The most common symptoms include:

• Proteinuria: This is the presence of protein in the urine, which often makes the urine appear foamy or bubbly ^[3].
• Edema: As the kidneys lose protein, fluid builds up in the body, leading to swelling in the legs, ankles, or feet ^[1].
• Nephrotic Syndrome: This is a cluster of symptoms—heavy proteinuria, low blood protein (albumin), and high cholesterol—found in many patients with AA kidney involvement ^[2].
• Digestive Issues: If the GI tract is involved, you may experience persistent diarrhea, weight loss, or difficulty absorbing nutrients ^[4][5].
• Organ Enlargement: Doctors may find an enlarged liver (hepatomegaly) or spleen (splenomegaly) during an exam ^[6].
• Cardiac Symptoms: Though less common than kidney involvement, amyloid can affect the heart, leading to breathlessness, fainting, or palpitations.

The Diagnostic Pathway: Biopsy and Staining

A diagnosis cannot be made through blood tests alone; it requires a biopsy, where a small piece of tissue is removed and examined under a microscope ^[7].

Where is the biopsy taken?

Doctors often start with the least invasive sites.

• Abdominal Fat Pad Aspiration: A simple needle is used to take a small sample of fat from under the skin of the belly ^[8][1].
• Rectal or GI Biopsy: Samples taken during an endoscopy. It is important that these biopsies are deep enough, as amyloid often hides in the deeper layers ^[9][5].
• Kidney Biopsy: Often considered the most definitive if kidney symptoms are present ^[10][7].

Important: A negative fat-pad or superficial GI biopsy does not entirely rule out amyloidosis. The deposits could have been missed in that specific sample. If suspicion remains high, your doctor may consider a biopsy of an affected organ, balancing the diagnostic need with procedural risks ^[8].

The Congo Red Stain

Once the tissue is collected, it is treated with a special dye called Congo red. When viewed under polarized light, amyloid typically glows with a very specific “apple-green” color, known as birefringence ^[11][12]. This glow supports the diagnosis, though technical issues with the stain can occasionally lead to false negatives.

The Critical Step: Accurate Typing

Finding amyloid is only half the battle. Your team must prove it is the AA type. Distinguishing AA from AL amyloidosis (which is caused by a blood/plasma cell disorder) is the most critical part of your care ^[13].

Misdiagnosis is a major risk. Some patients have been mistakenly given aggressive chemotherapy for AL amyloidosis when they actually had AA amyloidosis ^[14][15]. While doctors will run blood and urine tests (like serum free light chains and immunofixation) to look for a plasma cell disorder, these tests alone cannot definitively type the tissue, especially because a mild blood abnormality can coexist with AA amyloidosis ^[16].

The Role of Mass Spectrometry

While many labs use immunohistochemistry (using antibodies to “tag” the AA protein), this method can sometimes give unclear results ^[17][18].

When available, laser microdissection followed by mass spectrometry (LMD-MS) is an excellent reference method ^[19]. In this process, a laser cuts out the amyloid deposits, and a machine identifies the specific proteins within them ^[17][20]. It is highly accurate when there is an adequate tissue sample, confirming whether the protein is SAA (AA type) or a light chain (AL type). If mass spectrometry is unavailable or the sample is inadequate, expert validated immunostaining is used.

What Happens After Diagnosis?

Once AA amyloidosis is confirmed, your care team will take several next steps:

1. Assess Kidney Function: You will have blood tests for your creatinine and eGFR (estimated glomerular filtration rate) and a quantitative test for urine protein.
2. Evaluate Other Organs: Tests like an echocardiogram or liver function tests may be ordered to check for wider involvement.
3. Identify the Driver: If the underlying inflammatory disease is not already known, doctors will perform directed investigations to find it.
4. Pathology Report Review: Ensure your report confirms Congo red positivity and specifically types the amyloid as AA.